Mustafa Yıldırım

Mustafa Yıldırım

Auto-generated profile, based on publicly available information

Mustafa Yıldırım

Department of Ophthalmology, Atatürk University Faculty of Medicine, Erzurum, Türkiye

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2025 in The Eurasian Journal of Medicine
Verified
Journal Article
Open access
MYMustafa Yıldırım
Mustafa Yıldırım
EÇEmine Çinici
Emine Çinici
MÇMuhammet Çelik
Muhammet Çelik
SISelcan İçTaş
Selcan İçTaş
Background: The study aims to evaluate serum endocan (endothelial cell-specific molecule-1) levels in patients with type 2 diabetes mellitus and to determine its relationship with disease activity by comparing it with a control group. Methods: Venous blood samples were collected from 63 patients with diabetic retinopathy and healthy indi viduals who visited the policlinic between January 1, 2020, and March 1, 2020. Serum endocan and HbA1c levels were evaluated in the patients. Results: The mean age of the patient and control groups was 62 ± 10.19 and 60.27 ± 5.53, respectively. No statistically significant difference was observed between the patient and control groups in terms of age and gender. Serum endocan levels were found to be statistically significantly higher in the patient group with diabetic retinopathy (P < .05). Conclusion: It was hypothesized that serum endocan levels could serve as a guiding parameter in assessing the severity of diabetic retinopathy. Cite this article as: Yıldırım M, Çinici E, Çelik M, İçtaş S. Assessment of serum endothelial cell-specific molecule-1 (ESM-1, endocan) levels in patients with diabetic retinopathy. Eurasian J Med. 2025, 57(4), 1038, doi:10.5152/eurasianjmed.2025.251038.